AzizRK. (2018). Interview with Prof. Ramy K. Aziz, Cairo University. The dawn of pharmacomicrobiomics. OMICS, 22, 295–297.
2.
AzizRK, HegazySM, YasserR, RizkallahMR, and ElrakaibyMT. (2018). Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions. Expert Opin Drug Metab Toxicol, 14, 1043–1055.
3.
LeyRE, KnightR, and GordonJI. (2007). The human microbiome: eliminating the biomedical/environmental dichotomy in microbial ecology. Environ Microbiol, 9, 3–4.
4.
LiM, WangB, ZhangM, et al. (2008).Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA 105, 2117–2122.
5.
NuwaysirEF, BittnerM, TrentJ, BarrettJC, and AfshariCA. (1999). Microarrays and toxicology: the advent of toxicogenomics. Mol Carcinog, 24, 153–159.
